These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 7966134

  • 21. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
    Barone R, Walrand S, Konijnenberg M, Valkema R, Kvols LK, Krenning EP, Pauwels S, Jamar F.
    Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
    [Abstract] [Full Text] [Related]

  • 22. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
    Dabasi G, Hauser P, Kertész GP, Balázs G, Karádi Z, Constantin T, Bognár L, Klekner A, Schuler D, Garami M.
    Magy Onkol; 2007 Mar; 51(3):229-34. PubMed ID: 17922063
    [Abstract] [Full Text] [Related]

  • 23. Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
    Capello A, Krenning EP, Breeman WA, Bernard BF, Konijnenberg MW, de Jong M.
    Cancer Biother Radiopharm; 2003 Oct; 18(5):761-8. PubMed ID: 14629824
    [Abstract] [Full Text] [Related]

  • 24.
    Zhang H.
    ; 2004 Oct. PubMed ID: 20641372
    [Abstract] [Full Text] [Related]

  • 25. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
    Bakker WH, Krenning EP, Reubi JC, Breeman WA, Setyono-Han B, de Jong M, Kooij PP, Bruns C, van Hagen PM, Marbach P.
    Life Sci; 1991 Oct; 49(22):1593-601. PubMed ID: 1658516
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanisms of action of long-acting analogs of somatostatin.
    Chen F, O'Dorisio MS, Hermann G, Hayes J, Malarkey WB, O'Dorisio TM.
    Regul Pept; 1993 Apr 08; 44(3):285-95. PubMed ID: 8097891
    [Abstract] [Full Text] [Related]

  • 29. In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex.
    Lukinius A, Ohrvall U, Westlin JE, Oberg K, Tiensuu Janson E.
    Acta Oncol; 1999 Apr 08; 38(3):383-7. PubMed ID: 10380832
    [Abstract] [Full Text] [Related]

  • 30. Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats.
    Laznickova A, Laznicek M, Trejtnar F, Melicharova L, Suzuki KH, Akizawa H, Arano Y, Yokoyama A.
    Eur J Drug Metab Pharmacokinet; 2002 Apr 08; 27(1):37-43. PubMed ID: 11996325
    [Abstract] [Full Text] [Related]

  • 31. Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
    Marienhagen J, Schalke B, Aebert H, Held P, Eilles C, Bogdahn U.
    Pathol Res Pract; 1999 Apr 08; 195(8):575-81. PubMed ID: 10483589
    [Abstract] [Full Text] [Related]

  • 32. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
    Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WA, Lamberts SW.
    Endocrinology; 1995 Sep 08; 136(9):3698-706. PubMed ID: 7649075
    [Abstract] [Full Text] [Related]

  • 33.
    Shan L.
    ; 2004 Sep 08. PubMed ID: 22479715
    [Abstract] [Full Text] [Related]

  • 34. 110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.
    Lubberink M, Tolmachev V, Widström C, Bruskin A, Lundqvist H, Westlin JE.
    J Nucl Med; 2002 Oct 08; 43(10):1391-7. PubMed ID: 12368379
    [Abstract] [Full Text] [Related]

  • 35. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
    Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ.
    J Nucl Med; 1992 May 08; 33(5):652-8. PubMed ID: 1349039
    [Abstract] [Full Text] [Related]

  • 36. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
    Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester HJ, Schwaiger M.
    J Nucl Med; 2006 Apr 08; 47(4):566-73. PubMed ID: 16595488
    [Abstract] [Full Text] [Related]

  • 37. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.
    Q J Nucl Med; 1995 Dec 08; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [Abstract] [Full Text] [Related]

  • 38. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB, Nilsson O, Bejegård SA, Kölby L, Bernhardt P, Mölne J, Hashemi SH, Wängberg B, Tisell LE, Ahlman H.
    J Nucl Med; 2000 Apr 08; 41(4):636-42. PubMed ID: 10768564
    [Abstract] [Full Text] [Related]

  • 39. Solid-phase synthesis of huwentoxin-I and its structure and bioactivity analysis.
    Liang S, Xia Z, Xie J.
    Sci China C Life Sci; 1997 Oct 08; 40(5):449-57. PubMed ID: 20229294
    [Abstract] [Full Text] [Related]

  • 40. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M.
    Eur J Nucl Med Mol Imaging; 2005 Nov 08; 32(11):1288-95. PubMed ID: 16021448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.